159 related articles for article (PubMed ID: 32433820)
1. FOXO1 suppresses PGC-1β gene expression in skeletal muscles.
Nakai S; Oyabu M; Hatazawa Y; Akashi S; Kitamura T; Miura S; Kamei Y
FEBS Open Bio; 2020 Jul; 10(7):1373-1388. PubMed ID: 32433820
[TBL] [Abstract][Full Text] [Related]
2. IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator-1α in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway.
Mu X; Qi W; Liu Y; Zhou J; Li Y; Rong X; Lu L
Mol Cell Biochem; 2017 Aug; 432(1-2):199-208. PubMed ID: 28374141
[TBL] [Abstract][Full Text] [Related]
3. FOXO1 delays skeletal muscle regeneration and suppresses myoblast proliferation.
Yamashita A; Hatazawa Y; Hirose Y; Ono Y; Kamei Y
Biosci Biotechnol Biochem; 2016 Aug; 80(8):1531-5. PubMed ID: 27010781
[TBL] [Abstract][Full Text] [Related]
4. PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle.
Southgate RJ; Bruce CR; Carey AL; Steinberg GR; Walder K; Monks R; Watt MJ; Hawley JA; Birnbaum MJ; Febbraio MA
FASEB J; 2005 Dec; 19(14):2072-4. PubMed ID: 16203862
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.
Kamei Y; Miura S; Suzuki M; Kai Y; Mizukami J; Taniguchi T; Mochida K; Hata T; Matsuda J; Aburatani H; Nishino I; Ezaki O
J Biol Chem; 2004 Sep; 279(39):41114-23. PubMed ID: 15272020
[TBL] [Abstract][Full Text] [Related]
6. The cathepsin L gene is a direct target of FOXO1 in skeletal muscle.
Yamazaki Y; Kamei Y; Sugita S; Akaike F; Kanai S; Miura S; Hirata Y; Troen BR; Kitamura T; Nishino I; Suganami T; Ezaki O; Ogawa Y
Biochem J; 2010 Mar; 427(1):171-8. PubMed ID: 20088826
[TBL] [Abstract][Full Text] [Related]
7. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.
Sandri M; Lin J; Handschin C; Yang W; Arany ZP; Lecker SH; Goldberg AL; Spiegelman BM
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16260-5. PubMed ID: 17053067
[TBL] [Abstract][Full Text] [Related]
8. PGC-1β modulates statin-associated myotoxicity in mice.
Singh F; Zoll J; Duthaler U; Charles AL; Panajatovic MV; Laverny G; McWilliams TG; Metzger D; Geny B; Krähenbühl S; Bouitbir J
Arch Toxicol; 2019 Feb; 93(2):487-504. PubMed ID: 30511338
[TBL] [Abstract][Full Text] [Related]
9. PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading.
Wang J; Wang F; Zhang P; Liu H; He J; Zhang C; Fan M; Chen X
Biosci Biotechnol Biochem; 2017 Mar; 81(3):500-513. PubMed ID: 27869526
[TBL] [Abstract][Full Text] [Related]
10. PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism.
Lee J; Salazar Hernández MA; Auen T; Mucka P; Lee J; Ozcan U
Mol Metab; 2018 Jan; 7():119-131. PubMed ID: 29129613
[TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
12. Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle.
Menconi MJ; Arany ZP; Alamdari N; Aversa Z; Gonnella P; O'Neal P; Smith IJ; Tizio S; Hasselgren PO
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E533-43. PubMed ID: 20647557
[TBL] [Abstract][Full Text] [Related]
13. FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting.
Oyabu M; Takigawa K; Mizutani S; Hatazawa Y; Fujita M; Ohira Y; Sugimoto T; Suzuki O; Tsuchiya K; Suganami T; Ogawa Y; Ishihara K; Miura S; Kamei Y
FASEB J; 2022 Feb; 36(2):e22152. PubMed ID: 35061305
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise.
Miura S; Kai Y; Kamei Y; Ezaki O
Endocrinology; 2008 Sep; 149(9):4527-33. PubMed ID: 18511502
[TBL] [Abstract][Full Text] [Related]
15. Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury.
Zhang M; Dong W; Li Z; Xiao Z; Xie Z; Ye Z; Liu S; Li R; Chen Y; Zhang L; Wang M; Liang H; Baihetiyaer R; Apaer R; Dong Z; Liang X
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F262-F272. PubMed ID: 33356954
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-γ coactivator-1α expression in skeletal muscle.
Bocco BM; Louzada RA; Silvestre DH; Santos MC; Anne-Palmer E; Rangel IF; Abdalla S; Ferreira AC; Ribeiro MO; Gereben B; Carvalho DP; Bianco AC; Werneck-de-Castro JP
J Physiol; 2016 Sep; 594(18):5255-69. PubMed ID: 27302464
[TBL] [Abstract][Full Text] [Related]
17. Prmt7 Deficiency Causes Reduced Skeletal Muscle Oxidative Metabolism and Age-Related Obesity.
Jeong HJ; Lee HJ; Vuong TA; Choi KS; Choi D; Koo SH; Cho SC; Cho H; Kang JS
Diabetes; 2016 Jul; 65(7):1868-82. PubMed ID: 27207521
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
[TBL] [Abstract][Full Text] [Related]
19. Adult expression of PGC-1α and -1β in skeletal muscle is not required for endurance exercise-induced enhancement of exercise capacity.
Ballmann C; Tang Y; Bush Z; Rowe GC
Am J Physiol Endocrinol Metab; 2016 Dec; 311(6):E928-E938. PubMed ID: 27780821
[TBL] [Abstract][Full Text] [Related]
20. Effects of fenofibrate and its combination with lovastatin on the expression of genes involved in skeletal muscle atrophy, including FoxO1 and its targets.
Ajima H; Kai Y; Fujimaki J; Akashi S; Morita A; Ezaki O; Kamei Y; Miura S
J Toxicol Sci; 2021; 46(1):11-24. PubMed ID: 33408297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
